Glenmark Life Sciences Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Glenmark Life Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
49.28% Gain from 52W Low
10.6
TTM PE Ratio
Below industry Median
21.6
Price to Book Ratio
Below industry Median
4.4
Dividend yield 1yr %
High in industry
2.7
TTM PEG Ratio
PEG TTM is much higher than 1
25.7
RSI
RSI is mid-range
45.2
MFI
MFI is mid-range
47.8

Glenmark Life Sciences Ltd shareholding Pattern

Promoter
82.8%
Foreign Institutions
5%
Mutual Funds
0.9%
Domestic Institutions
1.4%
Public
10.7%
Promoter
82.8%
Foreign Institutions
4.6%
Mutual Funds
0.6%
Domestic Institutions
0.7%
Public
11.8%
Promoter
82.8%
Foreign Institutions
4.4%
Mutual Funds
0.4%
Domestic Institutions
0.6%
Public
12.1%
Promoter
82.8%
Foreign Institutions
3.3%
Mutual Funds
0.5%
Domestic Institutions
0.6%
Public
13.3%
Promoter
82.8%
Foreign Institutions
3.3%
Public
13.9%
Promoter
82.8%
Foreign Institutions
4.4%
Domestic Institutions
0.1%
Public
12.6%

Glenmark Life Sciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
10
5Day EMA
842.60
10Day EMA
846.80
12Day EMA
846.90
20Day EMA
844.30
26Day EMA
841.50
50Day EMA
830.40
100Day EMA
804.40
200Day EMA
746.70
5Day SMA
845.10
10Day SMA
855.90
20Day SMA
845.20
30Day SMA
838.00
50Day SMA
829.70
100Day SMA
824.90
150Day SMA
775.00
200Day SMA
738.20
Delivery & Volume
Resistance & Support
834.18
Pivot
Resistance
First Resistance
842.57
Second Resistance
855.38
Third Resistance
863.77
Support
First Support
821.37
Second support
812.98
Third Support
800.17
Relative Strength Index
45.22
Money Flow Index
47.81
MACD
5.40
MACD Signal
8.54
Average True Range
26.58
Average Directional Index
18.42
Rate of Change (21)
-0.30
Rate of Change (125)
28.56
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Caplin Point Laboratories Ltd.
10811.45
781.85
1619.05
Granules India Ltd.
11891.82
281.35
498.75
Jubilant Pharmova Ltd.
11470.4
318.75
775
Neuland Laboratories Ltd.
8431.42
2727
7790
Strides Pharma Science Ltd.
8689.81
405.45
993.85
Wockhardt Ltd.
8855.84
213.25
630

Glenmark Life Sciences Ltd Company background

Founded in: 2011
Managing director: Yasir Yusufali Rawjee
The company was incorporated as Zorg Laboratories Private Limited, a private limited company under the Companies Act, 1956 on 23 June 2011 at Pune and was granted the certificate of incorporation by the Registrar of Companies, Maharashtra at Pune (RoC). Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited pursuant to a special resolution passed by the shareholders of the Company on 25 July 2018 and a fresh certificate of incorporation dated 10 August 2018 was issued by the RoC. A shareholders resolution was passed on 13 August 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited. The Company acquired API division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January 2019.The company is primarily engaged in the business of development,manufacture and marketing of Active Pharmaceutical Ingredients(APIs). The companys RD facilities are located at Mahape,Ankleshwar and Dahej and manufacturing facilities are located at Ankleshwar,Dahej,Mohol and Kurkumbh.During the year 201819, the company allotted 4,50,090 Equity Shares of Rs. 10/ each on the conversion of loan given to Director. During the year, 15,00,000 equity shares of the face value of Rs. 10 each fully paidup issued to Glenmark Pharmaceuticals Limited (Parent Company) pursuant to the Preferential Allotment. Subsequent to the quarter ended 30 June 2021, the company has completed the IPO of 21,022,222 equity shares comprising a fresh issue of 14,722,222 equity shares and offer for sale of 6,300,000 equity shares of face value of Rs 2 each at premium of Rs 718 per share aggregating to Rs 15,136 million. Pursuant to the IPO, the equity shares of the Company are listed on BSE Limited and National Stock Exchange of India Limited with effect from 06 August 2021.The Gross Debt comprising of Outstanding Purchase Consideration payable to the Parent Company was Rs 8,008.3 million as on 09 July 2021.The Company has repaid the whole of this remaining outstanding purchase consideration from the proceeds of the Fresh Issue pursuant to the IPO.
Read More

Glenmark Life Sciences Ltd FAQs

Glenmark Life Sciences Ltd shares are currently priced at 829.75 on NSE and 829.3 on BSE as of 6/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Glenmark Life Sciences Ltd [GLS] share was 44.01. The Glenmark Life Sciences Ltd [GLS] share hit a 1-year low of Rs. 555.85 and a 1-year high of Rs. 906.

The market cap of Glenmark Life Sciences Ltd is Rs. 10166.69 Cr. as of 6/20/2024 12:00:00 AM.

The PE ratios of Glenmark Life Sciences Ltd is 21.58 as of 6/20/2024 12:00:00 AM.

The PB ratios of Glenmark Life Sciences Ltd is 4.35 as of 6/20/2024 12:00:00 AM

The Mutual Fund Shareholding was 0.93% at the end of 6/20/2024 12:00:00 AM.

You can easily buy Glenmark Life Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage